We assessed Calcofluor white staining, Aspergillus polymerase chain reaction, and a galactomannan enzyme immunoassay for diagnosis of fungal infection with use of computed tomography-guided percutaneous lung biopsy specimens obtained from 61 patients. The sensitivity and specificity of computerized tomography, Aspergillus polymerase chain reaction, and galactomannan enzyme immunoassay were 100% and 50%, 100% and 86%, and 88% and 94%, respectively.
Invasive aspergillosis (IA) is a major cause of morbidity and mortality among immunosuppressed patients. Case-fatality rates range from 30% to 80% among neutropenic patients, and death results, at least in part, from difficulties in obtaining a reliable diagnosis in the early stage of disease [1] . No method has proven to be sufficiently sensitive and specific to allow adequate diagnosis.
The use of CT allows diagnosis early in the course of pulmonary IA and helps to improve the overall survival rate among febrile, neutropenic patients [2] . Previous studies reported that the CT finding of a halo sign is indicative of pulmonary aspergillosis in neutropenic patients [3] . Thus far, it is impossible to distinguish Aspergillus species from other fungi on the basis of clinical signs [4] . However, identification of the causative organisms is highly warranted in the clinical context to deter-mine adequate therapy. Zygomycetes have in vivo and in vitro resistance to the newer antifungals, such as voriconazole and caspofungin [5] . The number of infections due to zygomycetes have increased in our hospital and in other health care centers, indicating the need for a powerful means of diagnosis [6] .
We evaluated the utility of Calcofluor white staining (CFWS), galactomannan EIA (GM EIA), and Aspergillus PCR of CTguided lung biopsy specimens for diagnosis of rapidly invasive fungal infection in immunosuppressed patients.
Methods. A prospective study conducted from October 2003 through September 2006 evaluated 61 patients who had hematologic malignancies (46 patients) or who had undergone solid-organ transplantation (15 patients) and who had CT findings highly suggestive of an invasive fungal infection. The specimens were obtained by CT-guided percutaneous biopsy and were investigated for the presence of fungal elements. All CTguided percutaneous biopsies were performed with an automated biopsy gun that contained a detachable coaxial cutting needle system, as described by Lucidarme et al. [7] . In our study, an outer coaxial needle with a 17-gauge diameter and an inner biopsy needle with an 18-gauge diameter were chosen. Interventions were performed only for patients with platelet counts of 50,000 platelets/mL and with prothrombin and partial thromboplastin times within the normal limits. Lesions that had a diameter 11 cm and that were most easily assessable were chosen for biopsy.
Biopsy specimens were transferred to 2 mL of NaCl, minced, and homogenized aseptically. Samples were then vortexed, stored at room temperature for 30 min, and centrifuged. Supernatants and homogenized tissues were examined for the presence of fungi by application of the Fungi-Fluor CFWS solution (Polysciences), by Aspergillus PCR [8] , and by GM EIA (Platelia Aspergillus ELISA; BioRad); a 0.5 cutoff optical density was used. In parallel, all samples were cultured in brain heart infusion broth at 37ЊC for 14 days. Selected samples that showed unseptate hyphae by CFWS and that yielded negative results of GM EIA and Aspergillus PCR were evaluated by a PCR specific for mucormycoses [9] . For controls, we examined 12 CT-guided lung biopsy specimens that had been obtained previously to rule out cancer or bacterial infection.
CTs were assessed for the presence and distribution of nodules, opacities (including ground glass opacities), halo signs, crescent signs, and cavitations. Proven pulmonary IA was defined as positive tissue biopsy specimen with typical septate, acute-branching hyphae, with or without an Aspergillus-positive culture. Non-Aspergillus fungal infection was defined as a pos- itive tissue biopsy specimen with typical unseptate, sparse, broad, and irregular hyphae, with or without a culture positive for any suitable fungus.
Results. In 61 patients, CT findings were highly suggestive of invasive fungal pneumonia. CFWS revealed that 49 samples (80%) were positive for fungal elements, and 12 samples (20%) yielded negative results. Septate and unseptate hyphae were noted for 36 specimens (73%) and 13 specimens (27%), respectively (table 1). Molecular identification of fungi detected Aspergillus species and Mucoraceae in all specimens, whereas culture results were positive for only 21 samples. With positive CFWS results used as a standard for comparison, the sensitivity and specificity for CT, Aspergillus PCR, and GM EIA of biopsy specimens were 100% and 50%, 100% and 86%, and 88% and 94%, respectively. Positive predictive values for CT, Aspergillus PCR, and GM EIA were 80%, 87%, and 94%, respectively. The rates of false-positive results for CT, Aspergillus PCR, and GM EIA were 50%, 13%, and 5%, respectively. CT revealed the presence of у1 halo sign in 185% of cases; an air crescent sign was observed in ∼30% of cases. In all but 3 patients, at least 2 chest CTs were performed.
Discussion. The performance of CFWS, Aspergillus PCR, and GM EIA of CT-guided biopsy specimens from the lung provided reliable tools for diagnosis of invasive fungal infection. CFWS was helpful for rapid differentiation of septate and unseptate hyphae, and the results helped guide decisions regarding adequate therapy. The clinical diagnosis of invasive pulmonary fungal infection is difficult to obtain, and in most cases, therapy is largely initiated on the basis of clinical findings and abnormal radiographic features.
In our study, 61 immunosuppressed patients had cases that were highly suggestive of IA on the basis of CT findings; examination of CT-guided biopsy specimens confirmed the diagnosis in 80% of patients, and negative results were obtained for 12 patients (20%). In 9 (75%) of these 12 patients, other clinical diagnoses (e.g., lung carcinoma, leukemic infiltrates, and tuberculosis) were confirmed by histopathologic examination of biopsy specimens. In 3 cases, however, the diagnosis of fungal infection was still considered in spite of negative CFWS results; the patients' clinical courses and responses to therapy confirmed the diagnosis of mycosis. Overall, the rate of false-negative results may be low. McCabe et al. [10] reported the clinical value of open lung biopsy in 15 patients with acute leukemia. For 2 patients (13%), autopsy revealed pulmonary fungal disease, which had not been detected by open lung biopsy before death. A similar rate was found by Cheson et al. [11] . The reasons for these findings are not known; perhaps fungi had been present in limited amounts.
For microbiologic concerns, many noninvasive methods fail to provide a reliable diagnosis, and percutaneous biopsies of intrapulmonary lesions are rarely performed in immunosuppressed patients. Contraindications, such as pulmonary hemorrhage with hemoptysis and infection, may account for the rare use of this procedure among immunosuppressed patients.
CFWS allowed a rapid diagnosis and the differentiation between septate and unseptate hyphae. Most Aspergillus species are susceptible voriconazole and caspofungin treatment; zygomycetes are not. Administration of amphotericin B at high doses has been the mainstay of medical treatment of zygomycosis [5] . In our study, at the time of diagnosis, 84% of the patients with proven zygomycosis received drugs that lacked activity against zygomycetes as primary therapy. The rapid identification of the causative agent resulted in administration of appropriate treatment and surgical intervention in 7 cases. The choice of agents in empirical therapy should be adapted to the local epidemiologic conditions. At our institution, Aspergillus terreus accounts for 120% of Aspergillus infections. The use of voriconazole and/or caspofungin therapy appeared to portend a better outcome in these cases [6] . However, the number of infections due to zygomycetes is increasing; thus, CT-guided biopsies are frequently performed to guide specific therapy. Cultures of bronchoalveolar lavage fluid specimens for diagnosis of fungal infections were not satisfactory for our patients. [5] . Fusarium and Scedosporium species may not be distinguishable from Aspergillus species on the basis of hyphal morphology in tissue specimens, but infections with these species require different antifungal treatments. The proper identification of the genus is highly warranted. Therefore, the application of CFWS plus Aspergillus PCR and/or GM EIA is recommended for an improved, rapid, and powerful diagnosis. Specificity and sensitivity of 100% were achieved by using these tests in combination. No differences in the fungal burdens (GM EIA) were detected in neutropenic patients, nonneutropenic patients, or patients who were receiving treatment. Marr et al. [12] reported that the utility of the serum antigen GM EIA was compromised during receipt of prophylactic or empirical antifungal treatments.
If the results of Aspergillus PCR and/or GM EIA remain negative, the health care provider should have a high level of suspicion that patient has zygomycosis rather than aspergillosis, because other fungi were not common in our setting. Therapy should be changed to drugs with activity against the zygomycetes, and a PCR specific for mucormycosis should be used. In our study, a zygomycetes PCR yielded successful results in 5 cases, although culture results remained negative. However, with unknown agents, sequence-based identification is probably the best candidate for identification of a wide range of fungi. In the event of negative CFWS results, GM EIA and/or Aspergillus PCR can be used to confirm the diagnoses. Overall, culture techniques were not helpful in identification of the infection, because 68% of the cultures of all specimens yielded negative results.
Although biopsy yielded a specific, clinically helpful diagnosis in patients with mucormycosis, 46% of the patients in our study died during hospitalization. The poor outcome may have resulted from a relative lack of susceptibility of zygomycetes to the therapeutic interventions or from lack of early adequate therapy. Recently, Chamilos et al. [4] defined clinical and radiological parameters typical for pulmonary zygomycoses. Whether these criteria improve patient treatment needs further validation.
CFWS was superior for detection of fungal elements and for distinguishing between septate and unseptate hyphae. Combination of CFWS with GM EIA and/or Aspergillus PCR resulted in fast and reliable identification of the fungus.
